Skip to main content
. Author manuscript; available in PMC: 2016 Aug 11.
Published in final edited form as: Arch Pharm (Weinheim). 2013 Jan;346(1):23–33. doi: 10.1002/ardp.201200334

Table 3.

PDE5 inhibitory activity of tetrahydro-β-carboline-piperazinediones (23, 24).

Compound R Chirality PDE5 % inhibition at 10 μma) PDE5 inhibition IC50 (μm)b)
23 C2H5 6S, 12aR 81 1.71
24 C2H5 6S, 12aS 87 1
a)

Calculated from triplicate values.

b)

Calculated from 10 concentrations, each with double replicates.